Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Valion Bio, Inc. VBIO

Set alert

Price alert · VBIO

All alert types
0.53 USD -0.02 -3.47%

At close · Nov 2

0.50 -0.03 -5.16%

After hours · Nov 2, 5:47 PM ET

Bid
0.52 × 2
Ask
0.55 × 1
0.5155 Day range 0.584
0.5155 52-week range 67.50
YTD
-98.54%
1 year
-99.15%
Open
0.584
Prev close
0.55
Mkt cap
1.11M
Vol
93.96K
Avg vol
1.98M
EPS
-177.91
P/E
0.00
Div yield
0.00%
More statistics
Low
0.5155
High
0.584

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 31, 2026Split: 1 for 25
Signals (18)
NameDateAgo
MACD: Sell SignalOct 14, 20262 weeks ago
RSI: OversoldOct 14, 20262 weeks ago
RSI: OversoldSep 18, 20261 month ago
RSI: OversoldSep 8, 20261 month ago
RSI: OversoldAug 27, 20262 months ago
MACD: Buy SignalAug 25, 20262 months ago
MACD: Sell SignalAug 14, 20262 months ago
RSI: OversoldAug 12, 20262 months ago
MACD: Buy SignalAug 3, 20263 months ago
MACD: Sell SignalJul 21, 20263 months ago
RSI: OversoldJul 20, 20263 months ago
MACD: Buy SignalJun 25, 20264 months ago
MACD: Sell SignalJun 11, 20264 months ago
MACD: Buy SignalJun 10, 20264 months ago
SMA: BearishMay 13, 20265 months ago
SMA: BullishMay 11, 20265 months ago
SMA: BearishMay 8, 20265 months ago
SMA: BullishMay 4, 20266 months ago

Financial health

Altman Z-Score

-4.49 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -4.6×
FY 2020: -290×FY 2021: -330×FY 2022: -39.9×FY 2023: -15.4×FY 2024: -4.3×FY 2025: -7.5×FY 2026: -4.6×
FY 2020 5y median -7.5× FY 2026
P/S 0.0×
FY 2020: 2862×FY 2021: 1398×FY 2022: 269×FY 2023: 84.1×FY 2024: 30.3×FY 2025: 0.0×FY 2026: 0.0×
FY 2020 5y median 30.3× FY 2026
P/B 2.5×
FY 2020: 507×FY 2021: -1021×FY 2022: 25.5×FY 2023: 42.6×FY 2024: 10.0×FY 2025: 16.7×FY 2026: 2.5×
FY 2020 5y median 16.7× FY 2026
P/FCF -6.0×
FY 2020: -325×FY 2021: -397×FY 2022: -60.4×FY 2023: -17.3×FY 2024: -4.1×FY 2025: -7.4×FY 2026: -6.0×
FY 2020 5y median -7.4× FY 2026
EV/EBITDA -4.6×
FY 2020: -330×FY 2021: -363×FY 2022: -58.2×FY 2023: -15.3×FY 2024: -4.1×FY 2025: -9.9×FY 2026: -4.6×
FY 2020 5y median -9.9× FY 2026
EV/Sales 0.0×
FY 2020: 2857×FY 2021: 1398×FY 2022: 260×FY 2023: 82.5×FY 2024: 27.8×FY 2025: 0.0×FY 2026: 0.0×
FY 2020 5y median 27.8× FY 2026
FCF Yield -16.8%
FY 2020: -0.3%FY 2021: -0.3%FY 2022: -1.7%FY 2023: -5.8%FY 2024: -24.2%FY 2025: -13.5%FY 2026: -16.8%
FY 2020 5y median -13.5% FY 2026

Profitability

Gross Margin 0.0%
FY 2020: -69.8%FY 2021: -27.1%FY 2022: -3.7%FY 2023: 16.3%FY 2024: 24.4%FY 2025: 0.0%FY 2026: 0.0%
FY 2020 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2020: -867.4%FY 2021: -386.2%FY 2022: -448.1%FY 2023: -548.8%FY 2024: -701.1%FY 2025: 0.0%FY 2026: 0.0%
FY 2020 5y median -448.1% FY 2026
Net Margin 0.0%
FY 2020: -987.6%FY 2021: -423.1%FY 2022: -675.7%FY 2023: -548.7%FY 2024: -701.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2020 5y median -548.7% FY 2026
ROE -52.9%
FY 2020: -174.9%FY 2021: 309.2%FY 2022: -64.0%FY 2023: -278.1%FY 2024: -230.3%FY 2025: -223.1%FY 2026: -52.9%
FY 2020 5y median -223.1% FY 2026
ROIC -25.5%
FY 2020: -153.6%FY 2021: -1137.3%FY 2022: -40.3%FY 2023: -242.7%FY 2024: -208.8%FY 2025: -174.2%FY 2026: -25.5%
FY 2020 5y median -174.2% FY 2026
ROA -28.1%
FY 2020: -137.2%FY 2021: -237.7%FY 2022: -56.5%FY 2023: -171.8%FY 2024: -159.9%FY 2025: -201.5%FY 2026: -28.1%
FY 2020 5y median -159.9% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 104.8%FY 2022: 46.2%FY 2023: 46.4%FY 2024: -36.1%FY 2025: -100.0%FY 2026: 0.0%
FY 2020 FY 2026
Operating Income -78.8%
FY 2020: 0.0%FY 2021: 8.8%FY 2022: -69.6%FY 2023: -79.3%FY 2024: 18.4%FY 2025: 46.4%FY 2026: -78.8%
FY 2020 FY 2026
EPS (diluted) 60.2%
FY 2020: 0.0%FY 2021: 12.3%FY 2022: -519.1%FY 2023: 57.2%FY 2024: 90.0%FY 2025: 88.9%FY 2026: 60.2%
FY 2020 FY 2026
Free Cash Flow -22.9%
FY 2020: 0.0%FY 2021: 18.2%FY 2022: -85.4%FY 2023: -59.1%FY 2024: 3.4%FY 2025: 33.7%FY 2026: -22.9%
FY 2020 FY 2026

Financial Health

Current Ratio 20.1×
FY 2020: 4.6×FY 2021: 1.2×FY 2022: 11.7×FY 2023: 2.8×FY 2024: 3.3×FY 2025: 9.7×FY 2026: 20.1×
FY 2020 5y median 9.7× FY 2026
Quick Ratio 20.1×
FY 2020: 3.8×FY 2021: 1.0×FY 2022: 11.4×FY 2023: 2.4×FY 2024: 2.8×FY 2025: 8.5×FY 2026: 20.1×
FY 2020 5y median 8.5× FY 2026
Debt / Equity 0.4×
FY 2020: 0.0×FY 2021: -1.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×FY 2026: 0.4×
FY 2020 5y median 0.1× FY 2026
Net Debt / EBITDA 0.8×
FY 2020: 0.6×FY 2021: -0.1×FY 2022: 2.2×FY 2023: 0.3×FY 2024: 0.4×FY 2025: 0.5×FY 2026: 0.8×
FY 2020 5y median 0.5× FY 2026
Interest Coverage -54.1×
FY 2020: -8.2×FY 2021: -7.9×FY 2022: -3.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: -54.1×
FY 2020 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2020 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2020 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2025-12-31